MedTrace Logo

An mHealth Self-Management Program to Decrease Postoperative Symptom Distress

NCT02610894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-10-22

No results posted yet for this study

Summary

The purposes of this study are to determine if use of the Postoperative Care at Home (PoCAH) tailored self-management program delivered via mobile technology (a mobile app) after discharge to home will result in: 1) fewer and/or less intense patient symptoms (pain, nausea and vomiting, fatigue, sore throat, constipation, sleep dysfunction); 2) enhanced patient satisfaction, perceived self-efficacy, and quality of life; 3) lower healthcare resource use (patient to healthcare provider calls; unscheduled patient appointments with healthcare providers; and hospital readmission and emergency department use). A secondary objective is to assess how easy the mobile app was to use after orthopaedic ambulatory surgery.

Conditions

  • Orthopaedic Surgery

Interventions

OTHER

mHealth application (PoCAH)

Participants will have unlimited access to the mHealth app via iPad Mini for 5 days post-operatively to aid in pain management

OTHER

As usual standard discharge and care instructions

As usual standard discharge and care instructions are provided via iPad mini to orthopaedic ambulatory surgery patients.

Sponsors & Collaborators

  • Jan Odom Forren

    lead OTHER

Principal Investigators

  • Jan Odom Forren, PhD, RN · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-07
Primary Completion
2016-07-25
Completion
2016-07-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02610894 on ClinicalTrials.gov